mounjaro is a semaglutide vs. Ozempic—Best Choice for Diabetes & Weight Loss- WebDoctors Online Doctors are prescribing Ozempic, Mounjaro

Both forms of semaglutide have shown a favorable safety profile, with manageable side effects primarily related to gastrointestinal symptoms

These patients also implemented diet and lifestyle changes

In addition, Wegovy may have the following warnings and precautions: Thyroid cancer risk: Animal studies suggest Wegovy may cause thyroid tumors

These symptoms were typically transient and largely resolved as the participants adapted to the intervention within the first month

Nooms data show that members who are most engaged in building healthy habits in its digital program while using GLP-1s can achieve stronger outcomes than those who are less engaged or who rely on habit support without medication